CorMedix CRMD Current Income Tax Expense (Benefit)
Current Income Tax Expense (Benefit) at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:CurrentIncomeTaxExpenseBenefit.
The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about CorMedix's current income tax expense (benefit).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is CorMedix's current income tax expense (benefit)?
- CorMedix (CRMD) reported current income tax expense (benefit) of $3.19M in Q4 2025.
- How has CorMedix's current income tax expense (benefit) changed year-over-year?
- CorMedix's current income tax expense (benefit) increased by 1014.6% year-over-year, from -$348.75K to $3.19M.
- What is the long-term trend for CorMedix's current income tax expense (benefit)?
- Over 3 years (2021 to 2025), CorMedix's current income tax expense (benefit) has grown at a 173.2% compound annual growth rate (CAGR), from $626K to $12.76M.
- What does current income tax expense (benefit) mean?
- The total current-period income tax expense or benefit, representing the amount of taxes currently payable or refundable for the reporting period. This metric excludes deferred tax effects and provides a clear view of the immediate cash impact of taxation on the company's earnings. It is vital for understanding the company's short-term tax obligations and cash flow management.